Cash & equivalents increased 67.2%
Cash & equivalents changed +67.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +67.2% from the comparable as-filed period.
Debt changed -90.2% from the comparable as-filed period.
Gross margin changed +662 basis points from the comparable as-filed period.
Inventory changed -26.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -149.4% from the comparable as-filed period.
Operating income changed -827.4% from the comparable as-filed period.
Operating margin changed -483 basis points from the comparable as-filed period.
Stock-based compensation changed +26.1% from the comparable as-filed period.
Gross profit changed +19.7% from the comparable as-filed period.
Research & development changed +7.6% from the comparable as-filed period.
Revenue changed -0.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.